REGENERON PHARMACEUTICALS, INC. Deferred Tax Assets, Operating Loss Carryforwards
REGENERON PHARMACEUTICALS, INC. (REGN) had Deferred Tax Assets, Operating Loss Carryforwards of $137.00 thousand as of 2016-12-31, per its 10-K filed 2017-02-09.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2017-02-09
- 2016-12-31: Deferred Tax Assets, Operating Loss Carryforwards $137.00K.
- 2015-12-31: Deferred Tax Assets, Operating Loss Carryforwards $140.00K.
- 2014-12-31: Deferred Tax Assets, Operating Loss Carryforwards $150.00K.
- 2013-12-31: Deferred Tax Assets, Operating Loss Carryforwards $135.00K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2016-12-31 | $137.00K 10-K · filed 2017-02-09 |
| 2015-12-31 | $140.00K 10-K · filed 2017-02-09 |
| 2014-12-31 | $150.00K 10-K · filed 2016-02-11 |
| 2013-12-31 | $135.00K 10-K · filed 2015-02-12 |
| 2012-12-31 | $77.12M 10-K · filed 2014-02-13 |
| 2011-12-31 | $282.48M 10-K · filed 2013-02-15 |
| 2010-12-31 | $243.89M 10-K · filed 2012-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |